Indication
BRAF V600E Mutation Positive
2 clinical trials
3 products
Clinical trial
Combination of Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With Braf v600e-mutates Localised Colon or Upper Rectum Cancer (Neoraf Study)Status: Recruiting, Estimated PCD: 2024-08-01
Product
Encorafenib + CetuximabClinical trial
A Phase Ib Trial of Vemurafenib Plus Copanlisib to Enhance Radioiodine Avidity in Radioiodine-Refractory Thyroid CancersStatus: Completed, Estimated PCD: 2023-09-29
Product
VemurafenibProduct
Copanlisib